Showa Denko to Form JV which May Produce Alumina in Indonesia

Showa Denko K.K. (SDK) has reached agreement with PT. ANTAM Tbk of Indonesia, Straits Trading Amalgamated Resources Private Limited (STAR) of Singapore, and Marubeni Corporation of Japan to establish a joint venture company in the middle of next month for conducting a feasibility study for an integrated chemical grade alumina plant from the mining of bauxite ore in the Tayan district, West Kalimantan, Indonesia.

The JV will determine the amount of required investment and ways of financing while carrying out an environmental assessment. ¡¡Based on the results of the feasibility study, the four parties will decide whether or not they will implement the plan. If they decide to proceed, the JV will serve as the nucleus for carrying out the project.

SDK is currently producing chemical grade aluminum hydrate and alumina for non-smelting purpose at its Yokohama Plant and is selling the product mainly in the Japanese market for such applications as water clarifier, performance materials and electronics. These products are being produced from imported bauxite ore. All Japanese alumina manufacturers are disposing of the bauxite residue, which is generated through the process of alumina, consisting mainly of iron oxide and silicon dioxide, in the designated area of the Pacific Ocean based on the domestic law. SDK is planning to terminate the disposal of bauxite residue in the sea by 2015.

As the Tayan district has reserves of high-quality bauxite, the four parties are planning to build a world-scale 300,000 tons/year chemical grade alumina plant by using¡¡the bauxite ore in Tayan.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.